Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Infection|December 21, 2006
Development of candidemia on caspofungin therapy: a case reportC Cheung, Y Guo, P Gialanella, et al.
Infection and Immunity|September 24, 1998
Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infectionJ Rivera, M Feldmesser, M Cammer, et al.
Molecular and Cellular Biology|December 22, 1998
Melanization of Cryptococcus neoformans in murine infectionJ D Nosanchuk, P Valadon, M Feldmesser, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacyJ Mukherjee, M Feldmesser, M D Scharff, et al.
The Journal of Biological Chemistry|April 16, 1998
Molecular characterization of a cDNA that encodes six isoforms of a novel murine A kinase anchor proteinF Dong, M Feldmesser, A Casadevall, et al.
Infection and Immunity|May 1, 1997
Eosinophil-Cryptococcus neoformans interactions in vivo and in vitroM Feldmesser, A Casadevall, Y Kress, et al.
Infection and Immunity|May 19, 2000
Antibody interactions with the capsule of Cryptococcus neoformansM Feldmesser, J Rivera, Y Kress, et al.
The Journal of Infectious Diseases|May 27, 2008
Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposureT M Hohl, M Feldmesser, D S Perlin, et al.
Infection and Immunity|September 13, 2001
Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformansD O Beenhouwer, S Shapiro, M Feldmesser, et al.
Brain Research|March 26, 1984
Pain-induced vocalization in the rat and its modification by pharmacological agentsJ D Levine, M Feldmesser, L Tecott, et al.
Pageof 3